wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38075446-0C1890AC-92D6-4F23-B058-834064B4DED6
Q38075446-0C1890AC-92D6-4F23-B058-834064B4DED6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38075446-0C1890AC-92D6-4F23-B058-834064B4DED6
Tasquinimod: a novel angiogenesis inhibitor-development in prostate cancer.
P2860
Q38075446-0C1890AC-92D6-4F23-B058-834064B4DED6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38075446-0C1890AC-92D6-4F23-B058-834064B4DED6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4f291fa014eedf83071f0645919d66572d97480c
P2860
Phase II randomized, double-blind, placebo-controlled study of tasquinimod in men with minimally symptomatic metastatic castrate-resistant prostate cancer.